Figure 6.
TEMPO polymerization improves ROS scavenging with systemic administration in a footpad model of inflammation. (A) Representative IVIS images of luminol signal in C57/Bl6 mouse paws after carrageenan injection and polymer treatment. Carrageenan inflammation was allowed to establish for 6 h, followed by i.v. injection of treatments. All treatments were matched at a TEMPO dose of 377 nmol. (B) Luminol signal normalized to carrageenan + saline treated group. **p < 0.005.
